[EN] BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR<br/>[FR] BENZOIMIDAZOL-2-YLPYRIMIDINES MODULATRICES DU RÉCEPTEUR DE L'HISTAMINE H4
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2014138368A1
公开(公告)日:2014-09-12
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.